Houston's life sciences market was waiting for demand to catch up to new supply. Now, threats to federal research funding ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

DP_Houston 2 (Paredes, Altuve, Walker; Peña, Walker). Inherited runners-scored_Ort 1-0. HBP_Littell (Peña), Okert (Mead). WP_Littell.

Astros second. Victor Caratini doubles to shallow right field. Jake Meyers doubles to deep center field. Victor Caratini scores. Zach Dezenzo called out on strikes. Cam Smith grounds out to third base ...

Target said Wednesday that it now expects a low-single digit decline in sales for 2025, and earnings per share, which ...

Shares rose in Asia on Wednesday while oil prices jumped more than $1.20 a barrel following a report that Israel may be ...

Eli Lilly is to buy the private biotech Disarm Therapeutics, which is working on a new class of disease-modifying drugs for neurological diseases, in a deal worth up to $1.36 billion.

Ouachita Baptist University has named 471 students to its President’s List for the Spring 2025 semester. To qualify for the ...